These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 15248822

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Vitamin D-binding protein levels in female patients with primary hyperparathyroidism.
    Wang X, Shapses SA, Wei S, Sukumar D, Ghosh J.
    Endocr Pract; 2013; 19(4):609-13. PubMed ID: 23425651
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
    Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S, Nagasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H.
    Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Influence of renal function on clinico-pathological features of primary hyperparathyroidism.
    Yamashita H, Noguchi S, Uchino S, Watanabe S, Murakami T, Ogawa T, Masatsugu T, Takamatsu Y, Miyatake E, Yamashita H.
    Eur J Endocrinol; 2003 Jun; 148(6):597-602. PubMed ID: 12773130
    [Abstract] [Full Text] [Related]

  • 52. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K, Masajtis-Zagajewska A, Nowicki M.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [Abstract] [Full Text] [Related]

  • 53. Clinical significance of FGF-23 measurement in dialysis patients.
    Jongbloed F, Galassi A, Cozzolino M, Zietse R, Chiarelli G, Cusi D, Brancaccio D, Gallieni M.
    Clin Nephrol; 2011 Sep; 76(3):201-9. PubMed ID: 21888857
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H.
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [Abstract] [Full Text] [Related]

  • 58. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F, Fernández MA, Ruiz-Calero R, Cubero J, Aparicio A, Jimenez F, García MC.
    Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
    [Abstract] [Full Text] [Related]

  • 59. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.
    Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T.
    J Bone Miner Res; 2004 Mar; 19(3):429-35. PubMed ID: 15040831
    [Abstract] [Full Text] [Related]

  • 60. Fibroblast growth factor 23 concentrations in humoral hypercalcemia of malignancy and hyperparathyroidism.
    Singh RJ, Kumar R.
    Mayo Clin Proc; 2003 Jul; 78(7):826-9. PubMed ID: 12839077
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.